Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Lithium
100%
Sepsis
100%
Glycogen Synthase Kinase 3 (GSK3)
100%
Lithium Chloride
62%
Phosphorylation
50%
Mammalian Target of Rapamycin (mTOR)
25%
Proteolysis
25%
Eukaryotic Initiation Factor 2B (eIF2B)
25%
Muscle Protein Degradation
25%
Autophagy
25%
Glycogen Synthase kinase-3 Inhibitors
25%
Incubation
12%
Protein Synthesis
12%
4E-BP1
12%
Kinase Activity
12%
Skeletal muscle
12%
EIF2
12%
Muscle Protein Synthesis
12%
Eukaryotic Initiation Factor-2B
12%
Protein Synthesis Inhibition
12%
Basal Conditions
12%
Target of Rapamycin Kinase
12%
Forkhead Box O3 (FOXO3)
12%
Lithium Treatment
12%
LC3-II
12%
Sepsis Treatment
12%
In Vivo Applications
12%
Protein Inhibition
12%
Lean Body Mass
12%
MuRF1
12%
Ubiquitin-proteosome
12%
Atrogin-1
12%
Neuroscience
In Vitro
100%
Lithium Chloride
100%
Muscle Protein
100%
Glycogen Synthase Kinase 3
100%
Protein Biosynthesis
60%
Mammalian Target of Rapamycin
40%
Proteolysis
40%
Autophagy
40%
Glycogen Synthase Kinase 3 Inhibitor
40%
Skeletal Muscle
20%
Atrogin 1
20%
Ubiquitin
20%
Guanine Nucleotide Exchange Factor
20%
Messenger RNA
20%
Pharmacology, Toxicology and Pharmaceutical Science
Sepsis
100%
Muscle Protein
100%
Glycogen Synthase Kinase 3
100%
Lithium Chloride
55%
Mammalian Target of Rapamycin
22%
Glycogen Synthase Kinase 3 Inhibitor
22%
Ubiquitin
11%
Initiation Factor 2
11%
Guanine Nucleotide Exchange Factor
11%
Atrogin 1
11%
Messenger RNA
11%
Biochemistry, Genetics and Molecular Biology